Operating Income: The income after operating expenses.
Bristol Myers Squibb Company (BMY) had Operating Income of $4.09B for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$12.97B |
|
$3.32B |
|
$3.73B |
|
$9.25B |
|
$8.89B |
|
|
Operating Income |
$4.09B |
-- |
|
$4.09B |
|
$4.09B |
|
$3.32B |
|
$3.32B |
|
$3.32B |
|
$3.32B |
|
$4.09B |
|
$4.68B |
|
2.04B |
|
2.05B |
|
$1.62 |
|
$1.62 |
|
| Balance Sheet Financials | |
$28.58B |
|
$7.79B |
|
$59.05B |
|
$87.63B |
|
$18.66B |
|
$42.09B |
|
$46.66B |
|
$65.31B |
|
$22.32B |
|
$-16.81B |
|
$22.32B |
|
2.04B |
|
| Cash Flow Statement Financials | |
$4.50B |
|
$-1.75B |
|
$-4.19B |
|
$10.22B |
|
$8.72B |
|
$-1.50B |
|
$281.00M |
|
$-2.57B |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.53 |
|
-- |
|
-- |
|
0.65 |
|
1.93 |
|
71.28% |
|
31.50% |
|
31.50% |
|
-- |
|
31.50% |
|
25.57% |
|
$3.85B |
|
-- |
|
-- |
|
-- |
|
0.15 |
|
1.36 |
|
1.23 |
|
73.21 |
|
14.86% |
|
-19.73% |
|
3.78% |
|
5.15% |
|
$10.92 |
|
$1.88 |
|
$2.20 |
|